BEAMing up personalized medicine: Mutation detection in blood

Andrea L. Richardson, J. Dirk Iglehart

Research output: Contribution to journalComment/debate

Abstract

BEAMing is a feasible, accurate, and sensitive method for detection of PIK3CA mutations in circulating tumor DNA in blood. Mutation status of PIK3CA may change between primary tumor and recurrence. The results suggest a new approach for noninvasive determination of current mutation status in patients with metastatic disease.

Original languageEnglish (US)
Pages (from-to)3209-3211
Number of pages3
JournalClinical Cancer Research
Volume18
Issue number12
DOIs
StatePublished - Jun 15 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'BEAMing up personalized medicine: Mutation detection in blood'. Together they form a unique fingerprint.

  • Cite this